Conmed (CNMD) Net Income towards Common Stockholders (2016 - 2020)
Historic Net Income towards Common Stockholders for Conmed (CNMD) over the last 11 years, with Q4 2020 value amounting to $135.5 million.
- Conmed's Net Income towards Common Stockholders fell 455.08% to $135.5 million in Q4 2020 from the same period last year, while for Sep 2021 it was $135.5 million, marking a year-over-year decrease of 7096.72%. This contributed to the annual value of $47.1 million for FY2025, which is 6446.61% down from last year.
- Conmed's Net Income towards Common Stockholders amounted to $135.5 million in Q4 2020, which was down 455.08% from $133.7 million recorded in Q3 2020.
- In the past 5 years, Conmed's Net Income towards Common Stockholders ranged from a high of $142.0 million in Q4 2019 and a low of $71.9 million during Q2 2020
- Moreover, its 5-year median value for Net Income towards Common Stockholders was $113.4 million (2018), whereas its average is $114.5 million.
- Per our database at Business Quant, Conmed's Net Income towards Common Stockholders skyrocketed by 1761.23% in 2019 and then plummeted by 4517.19% in 2020.
- Quarter analysis of 5 years shows Conmed's Net Income towards Common Stockholders stood at $107.0 million in 2016, then increased by 15.89% to $124.0 million in 2017, then grew by 7.02% to $132.7 million in 2018, then grew by 7.03% to $142.0 million in 2019, then decreased by 4.55% to $135.5 million in 2020.
- Its last three reported values are $135.5 million in Q4 2020, $133.7 million for Q3 2020, and $71.9 million during Q2 2020.